Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-04-02-2012
Volume36
Issue 4

Q&A with Erik van den Berg, AM-Pharma

A Q&A with Erik van den Berg, CEO of AM-Pharma, on recent industry trends.

PharmTech:

How has the increasing focus on biopharmaceuticals affected your business?

Van den Berg:

AM-Pharma is solely focused on biopharmaceuticals. We have established proof-of-concept data with bovine alkaline phosphatase in the treatment of acute kidney injury. Now, we will manufacture recombinant human alkaline phosphatase and perform subsequent clinical studies with this recombinant material.

PharmTech:

How will the industry remain innovative as it reduces spending on research?

Van den Berg:

The large pharmaceutical companies have become dependent on external R&D. More than 50% of the clinical pipeline is derived from small biotech or academia. The reduced spending on research should be supplemented with higher investment in development and acquisition/licensing expenses.

PharmTech:

Do you see a new industry trend emerging?

Van den Berg:

The industry trend is towards more and more outsourcing of development activities.

PharmTech:

How is your company responding to regulators' intensifying emphasis on inspections and product quality?

Van den Berg:

Our quality system is aligned with industry expectations, which means that collaborations are managed by quality agreements and involve regular inspections. In addition, we maintain contact with the regulatory authorities early on in the development program to include their requests and recommendations.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Simona Guidi, Associate Director, ProPharma
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Behind the Headlines, Episode 18
Related Content